Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · IEX Real-Time Price · USD
1.690
-0.180 (-9.63%)
At close: Jul 2, 2024, 4:00 PM
1.720
+0.030 (1.78%)
After-hours: Jul 2, 2024, 6:30 PM EDT
Leap Therapeutics Market Cap
Leap Therapeutics has a market cap or net worth of $64.67 million as of July 2, 2024. Its market cap has increased by 42.75% in one year.
Market Cap
64.67M
Enterprise Value
8.98M
1-Year Change
42.75%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since January 25, 2017, Leap Therapeutics's market cap has decreased from $73.80M to $64.67M, a decrease of -12.38%. That is a compound annual growth rate of -1.76%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 71.60M | -32.45% |
Dec 29, 2023 | 106.00M | 137.67% |
Dec 30, 2022 | 44.60M | -84.42% |
Dec 31, 2021 | 286.20M | 113.26% |
Dec 31, 2020 | 134.20M | 395.20% |
Dec 31, 2019 | 27.10M | -7.82% |
Dec 31, 2018 | 29.40M | -49.83% |
Dec 29, 2017 | 58.60M | -20.60% |
Jan 25, 2017 | 73.80M | - |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SCYNEXIS | 73.67M |
Conduit Pharmaceuticals | 73.47M |
Serina Therapeutics | 73.03M |
CASI Pharmaceuticals | 72.37M |
Eagle Pharmaceuticals | 71.82M |
Milestone Pharmaceuticals | 71.37M |
Anixa Biosciences | 71.05M |
MediciNova | 70.63M |